Mirae Asset Global Investments
UTHR icon

Mirae Asset Global Investments’s United Therapeutics UTHR Stock Holding History

Mirae Asset Global Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Sell
4,119
-709
-15% -$399K ﹤0.01% 763
2026
Q1 		$2.86M Buy
4,828
+526
+12% +$262K ﹤0.01% 683
2025
Q4 		$2.1M Sell
4,302
-399
-8% -$186K 0.01% 774
2025
Q3 		$1.97M Buy
4,701
+685
+17% +$230K 0.01% 757
2025
Q2 		$1.15M Buy
4,016
+338
+9% +$101K ﹤0.01% 802
2025
Q1 		$1.13M Buy
3,678
+376
+11% +$129K ﹤0.01% 794
2024
Q4 		$1.18M Sell
3,302
-345
-9% -$127K ﹤0.01% 783
2024
Q3 		$1.31M Sell
3,647
-632
-15% -$213K 0.01% 751
2024
Q2 		$1.36M Sell
4,279
-8,510
-67% -$2.25M 0.01% 674
2024
Q1 		$2.87M Buy
+12,789
New +$2.89M 0.01% 1039
2021
Q4 		– Sell
-3,270
Closed -$604K – 1764
2021
Q3 		$604K Buy
3,270
+576
+21% +$113K ﹤0.01% 1447
2021
Q2 		$484K Buy
2,694
+1,415
+111% +$269K ﹤0.01% 1457
2021
Q1 		$214K Buy
+1,279
New +$213K ﹤0.01% 1483
2020
Q4 		– Sell
-2,160
Closed -$218K – 1584
2020
Q3 		$218K Buy
2,160
+451
+26% +$49.5K ﹤0.01% 1416
2020
Q2 		$206K Buy
+1,709
New +$192K ﹤0.01% 1391
2019
Q2 		– Sell
-1,793
Closed -$210K – 1417
2019
Q1 		$210K Buy
+1,793
New +$209K ﹤0.01% 1263
2016
Q1 		– Sell
-1,601
Closed -$251K – 514
2015
Q4 		$251K Buy
+1,601
New +$233K 0.01% 416
2015
Q3 		– Sell
-1,178
Closed -$205K – 484
2015
Q2 		$205K Buy
+1,178
New +$212K 0.01% 448

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's UTHR Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its United Therapeutics (UTHR) stake by 15% in Q2 2026, selling an estimated $399K and leaving 4,119 shares worth $2.23M. The position accounts for ﹤0.01% of the portfolio, ranked #763.

Mirae Asset Global Investments first reported a position in UTHR in Q2 2015 and has held it in 18 quarters since. The position peaked at $2.87M in Q1 2024. 450 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Mirae Asset Global Investments held 4,119 shares of United Therapeutics worth $2.23M as of Q2 2026.
  • Mirae Asset Global Investments sold 709 United Therapeutics shares in Q2 2026, an estimated $399K.
  • United Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #763 holding.
  • Mirae Asset Global Investments first reported a position in United Therapeutics in Q2 2015 and has held it in 18 quarters since.
  • Mirae Asset Global Investments's United Therapeutics position peaked at $2.87M in Q1 2024.
  • 450 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.